Want to join the conversation?
$ENDP 2Q15 PR: "Our diversified business delivered strong financial results for the quarter and demonstrated the value that we expect to create through the continued execution of our strategy," said Rajiv De Silva, President and CEO of Endo.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?